V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Row
T
TGTXAI Stock Diagnostic Report

TG Therapeutics down 11% following Q2 bottom line miss

TG Therapeutics' stock price fell by 11% due to a shortfall in expected net income for the second quarter.

View Source Article ↗
AI CATALYST SCORE40 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+
ANALYSIS HISTORY

TGTX Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-08-21 14:07:00TGTX75MidView Report →
2026-08-03 18:39:00TGTX40RowView Report →
2026-08-03 15:52:11TGTX85MidView Report →
View Full History for TGTX (Blueprint) →